Acute growth hormone administration induces antidiuretic and antinatriuretic effects and increases phosphorylation of NKCC2

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 2, 2007, Pages

  Dimke, Henrik ^a   Flyvbjerg, Allan ^b   Bourgeois, Soline ^b   Thomsen, Klaus ^a   Frøkiær, Jørgen ^c   Houillier, Pascal ^b   Nielsen, Søren ^a   Frische, Sebastian ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c INSERM   (France)

Author keywords

GH; Insulin like growth factor I; Kidney; Sodium; Thick ascending limb

Indexed keywords

AQUAPORIN 2; CREATININE; ELECTROLYTE; GROWTH HORMONE; LITHIUM; MESSENGER RNA; SODIUM CHLORIDE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIURESIS; APICAL MEMBRANE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; URINARY EXCRETION; URINE OSMOLALITY; URINE VOLUME;

EID: 33846886139     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00276.2006     Document Type: Article

References (66)

1. Barton JS, Hindmarsh PC, Preece MA, Brook CG. Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone. Clin Endocrinol (Oxf) 38: 245-251, 1993.
2. Bergenstal DM, Lipsett MB. Metabolic effects of human growth hormone and growth hormone of other species in man. J Clin Endocrinol Metab 20: 1247-1435, 1960.
3. Biglieri E, Watlington C, Forsham P. Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab 21: 361-370, 1961.
4. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 37: 79-87, 1992.
5. Bortz JD, Rotwein P, DeVol D, Bechtel PJ, Hansen VA, Hammerman MR. Focal expression of insulin-like growth factor I in rat kidney collecting duct. J Cell Biol 107: 811-819, 1988.
6. Chin E, Zhou J, Bondy C. Anatomical relationships in the patterns of insulin-like growth factor (IGF)-I, IGF binding protein-1, and IGF-I receptor gene expression in the rat kidney. Endocrinology 130: 3237-3245, 1992.
7. Christensen BM, Zelenina M, Aperia A, Nielsen S. Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol 278: F29-F42, 2000.
8. De Zegher F, Devlieger H, Veldhuis JD. Properties of growth hormone and prolactin hypersecretion by the human infant on the day of birth. J Clin Endocrinol Metab 76: 1177-1181, 1993.
9. Eden S. Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology 105: 555-560, 1979.
10. Epstein S, Le Roith D, Rabkin R. The effect of different preparations of human growth hormone on plasma renin activity in normal males. J Clin Endocrinol Metab 42: 390-392, 1976.
11. +-ATPase in rat collecting duct. J Physiol 488: 171-180, 1995.
12. Flemmer AW, Gimenez I, Dowd BF, Darman RB, Forbush B. Activation of the Na-K-Cl otransporter NKCC1 detected with a phosphospecific antibody. J Biol Chem 277: 37551-37558, 2002.
13. Fushimi K, Sasaki S, Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem 272: 14800-14804, 1997.
14. Garvin JL, Knepper MA. Bicarbonate and ammonia transport in isolated perfused rat proximal straight tubules. Am J Physiol Renal Fluid Electrolyte Physiol 253: F277-F281, 1987.
15. Gimenez I, Forbush B. Regulatory phosphorylation sites in the N-terminus of the renal Na-K-Cl cotransporter (NKCC2). Am J Physiol Renal Physiol 289: F1341-F1345, 2005.
16. Gimenez I, Forbush B. Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J Biol Chem 278: 26946-26951, 2003.
17. Giordano M, DeFronzo RA. Acute effect of human recombinant insulin-like growth factor I on renal function in humans. Nephron 71: 10-15, 1995.
18. Glafkides CM, Bennett LL. Reduction of urinary sodium and potassium of diabetic rats produced by hypophyseal growth hormone. Proc Soc Exp Biol Med 77: 524-526, 1951.
19. Good DW, Knepper MA, Burg MB. Ammonia and bicarbonate transport by thick ascending limb of rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 247: F35-F44, 1984.
20. Gronbaek H, Nielsen B, Schrijvers B, Vogel I, Rasch R, Flyvbjerg A. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice. J Endocrinol 172: 637-643, 2002.
21. Hansen TK, Moller J, Thomsen K, Frandsen E, Dall R, Jorgensen JO, Christiansen JS. Effects of growth hormone on renal tubular handling of sodium in healthy humans. Am J Physiol Endocrinol Metab 281: E1326-E1332, 2001.
22. Hayes FJ, Fiad TM, McKenna TJ. Activity of the renin-angiotensin-aldosterone axis is dependent on the occurrence of edema in growth hormone (GH)-deficient adults treated with GH. J Clin Endocrinol Metab 82: 322-323, 1997.
23. Hirschberg R, Brunori G, Kopple JD, Guler HP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43: 387-397, 1993.
24. Hizuka N, Takano K, Asakawa K, Fukuda I, Sukegawa I, Shizume K, Demura H. Single sc administration of insulin-like growth factor I (IGF-I) in normal men. Adv Exp Med Biol 293: 105-112, 1991.
25. Ho KY, Weissberger AJ. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 39: 133-137, 1990.
26. Honeyman TW, Goodman HM, Fray JC. The effects of growth hormone on blood pressure and renin secretion in hypophysectomized rats. Endocrinology 112: 1613-1617, 1983.
27. Ikkos D, Luft R, Sjogren B. Body water and sodium in patients with acromegaly. J Clin Invest 33: 989-994, 1954.
28. Isaksson OGP, Jansson J, Gause IAM. Growth hormone stimulates longitudinal bone growth directly. Science 216: 1237-1239, 1982.
29. Ito O, Kondo Y, Takahashi N, Omata K, Abe K. Role of calcium in insulin-stimulated NaCl transport in medullary thick ascending limb. Am J Physiol Renal Fluid Electrolyte Physiol 269: F236-F241, 1995.
30. Jensen LJN, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. J Endocrinol 188: 493, 2006.
31. Johannsson G, Sverrisdottir YB, Ellegard L, Lundberg PA, Herlitz H. GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis. J Clin Endocrinol Metab 87: 1743-1749, 2002.
32. Jorgensen KD. Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/antidiuretic and barbital sleep effects of human growth hormone in rats. Acta Endocrinol 114: 124-131, 1987.
33. Jorgensen PH, Bang C, Andreassen TT, Flyvbjerg A, Orskov H. Dose response study of the effect of growth hormone on mechanical properties of skin graft wounds. J Surg Res 58: 295-301, 1995.
34. Kim GH, Ecelbarger CA, Mitchell C, Packer RK, Wade JB, Knepper MA. Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. Am J Physiol Renal Physiol 276: F96-F103, 1999.
35. Lobie PE, Garcia-Aragon J, Wang BS, Baumbach WR, Waters MJ. Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130: 3057-3065, 1992.
36. Lockett MF, Nail B. A comparative study of the renal actions of growth and lactogenic hormones in rats. J Physiol 180: 147-156, 1965.
37. Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70: 519-527, 1990.
38. Maunsbach A. Embedding of cells and tissues for ultrastructural and immunocytochemical analysis. In: Cell Biology. A Laboratory Handbook, edited by Celis JE. San Diego, CA: Academic, 1994, p. 117-125.
39. Miller SB, Rotwein P, Bortz JD, Bechtel PJ, Hansen VA, Rogers SA, Hammerman MR. Renal expression of IGF I in hypersomatotropic states. Am J Physiol Renal Fluid Electrolyte Physiol 259: F251-F257, 1990.
40. Moller J, Jorgensen JO, Moller N, Hansen KW, Pedersen EB, Christiansen JS. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab 72: 768-772, 1991.
41. Moller J, Moller N, Frandsen E, Wolthers T, Jorgensen JO, Christiansen JS. Blockade of the renin-angiotensin-aldosterone system prevents growth hormone-induced fluid retention in humans. Am J Physiol Endocrinol Metab 272: E803-E808, 1997.
42. Moriguchi T, Urushiyama S, Hisamoto N, Iemura Si Uchida S, Natsume T, Matsumoto K, Shibuya H. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem 280: 42685-42693, 2005.
43. Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA 90: 11663-11667, 1993.
44. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
45. Nielsen S, Maunsbach AB, Ecelbarger CA, Knepper MA. Ultrastructural localization of Na-K-2Cl cotransporter in thick ascending limb and macula densa of rat kidney. Am J Physiol Renal Physiol 275: F885-F893, 1998.
46. Nishimoto G, Zelenina M, Li D, Yasui M, Aperia A, Nielsen S, Nairn AC. Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue. Am J Physiol Renal Physiol 276: F254-F259, 1999.
47. Ortiz PA. cAMP increases surface expression of NKCC2 in rat thick ascending limbs: role of VAMP. Am J Physiol Renal Physiol In press.
48. Pacheco-Alvarez D, San Cristobal P, Meade P, Moreno E, Vazquez N, Munoz E, Diaz A, Juarez ME, Gimenez I, Gamba G. The Na-Cl cotransporter is activated and phosphorylated at the amino terminal domain upon intracellular chloride depletion. J Biol Chem In press.
49. Pietrobelli DJ, Akopian M, Olivieri AO, Renauld A, Garrido D, Artese R, Feldstein CA. Altered circadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values. J Hum Hypertens 15: 601-605, 2001.
50. Quigley R, Baum M. Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 88: 368-374, 1991.
51. Rogers SA, Miller SB, Hammerman MR. Growth hormone stimulates IGF I gene expression in isolated rat renal collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 259: F474-F479, 1990.
52. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 38: 63-71, 1993.
53. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321: 1797-1803, 1989.
54. Satozawa N, Takezawa K, Miwa T, Takahashi S, Hayakawa M, Ooka H. Differences in the effects of 20 K- and 22 K-hGH on water retention in rats. Growth Horm IGF Res 10: 187-192, 2000.
55. Saunders A, Terry LC, Audet J, Brazeau P, Martin JB. Dynamic studies of growth hormone and prolactin secretion in the female rat. Neuroendocrinology 21: 193-203, 1976.
56. Simone PG, Solomon S. Aldosterone and growth hormone: influence of diet and hypophysectomy on rat renal response. Proc Soc Exp Biol Med 133: 786-789, 1970.
57. Sondergaard M, Dagnaes-Hansen F, Flyvbjerg A, Jensen TG. Normalization of growth in hypophysectomized mice using hydrodynamic transfer of the human growth hormone gene. Am J Physiol Endocrinol Metab 285: E427-E432, 2003.
58. Stein JD Jr, Bennett LL, Batts AA, Li CH. Sodium, potassium, and chloride retention produced by growth hormone in the absence of the adrenals. Am J Physiol 171: 587-591, 1952.
59. Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 37: 217-223, 1984.
60. Thomsen K, Shalmi M, Olesen OV. Effect of low dietary sodium and potassium on lithium clearance in rats. Miner Electrolyte Metab 19: 91-98, 1993.
61. Thomsen K, Shirley DG. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. Nephron 77: 125-138, 1997.
62. Welbourne TC, Cronin MJ. Growth hormone accelerates tubular acid secretion. Am J Physiol Regul Integr Comp Physiol 260: R1036-R1042, 1991.
63. Whitney JE, Bennett LL, Li CH. Reduction of urinary sodium and potassium produced by hypophyseal growth hormone in normal female rats. Proc Soc Exp Biol Med 79: 584-587, 1952.
64. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science 293: 1107-1112, 2001.
65. Wittner M, di Stefano A, Wangemann P, Nitschke R, Greger R, Bailly C, Amiel C, Roinel N, de Rouffignac C. Differential effects of ADH on sodium, chloride, potassium, calcium and magnesium transport in cortical and medullary thick ascending limbs of mouse nephron. Pflügers Arch 412: 516-523, 1988.
66. 2 interaction with AVP: effects on AQP2 phosphorylation and distribution. Am J Physiol Renal Physiol 278: F388-F394, 2000.